Resumen

ARANDA, Mónica  y  ROSASCO, María Ana. The pharmacy of generic drugs. Rev. colomb. cienc. quim. farm. [online]. 2019, vol.48, n.2, pp.357-371. ISSN 0034-7418.  https://doi.org/10.15446/rcciquifa.v48n2.82714.

Generic medicines give the chance to improve access to medicaments that the population needs, and the possibility of making public and private health programs more sustainable. Information and scientific evidence on this type of medicines has been selected in such a way that the readers - doctors, financiers, public and private organizations - can shape their own opinion and help take the most effective and efficient decisions. The relationship between the prices of these products and the protection of intellectual property through patents for medicines is a center of conflicts between the Pharmaceutical Industry and health systems. In the United States, the Hatch-Waxman Act has played a very important role in stimulating the development of generic drugs. By his side, the European Union (EU) has developed, through the European Medicines Agency (EMA), a homogenization in terms of authorization of medicines and exclusivity of data.

Palabras clave : Generics drugs; equivalence; bioequivalence; interchangeability; patents.

        · resumen en Español     · texto en Español     · Español ( pdf )